MAKING GREAT DRUGS BETTER

News

Securing Early-Stage Funding for Retinal Innovations – ASRS Retina Times Summer 20212 Publication with contribution from CEO Michael O’Rourke

by | Jun 9, 2021 | News | 0 comments

In the first 2 articles of the Retina Times Innovation and Entrepreneurship section, we discussed how to secure your intellectual property (IP), define your business model, assemble your team, and develop a quality management system (QMS). Here, we discuss fund raising for your idea.

We asked retina specialist and entrepreneur Firas Rahhal, MD, to assemble a group of experts and lead a roundtable discussion on early funding for retinal innovations. Our panel includes 2 seasoned inventor/entrepreneurs with a unique university perspective, a successful pharmaceutical start-up company chief executive officer (CEO}, and a co-founder and partner of a venture capital (VC) firm specializing in biotechnology.

Mark S Blumenkranz MD, MMS
Mark S. Humayun, MD, PhD, FASRS
Michael O'Rourke
Michael O’Rourke, BSc (Hons)
Stella Robertson, PhD

Read the entire article >>

Download article (PDF 2MB) >> Download

Re-Vana: Vision In The Future